| 000 | 01535 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513110450.0 | ||
| 264 | 0 | _c19970122 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0902-4441 | ||
| 024 | 7 |
_a10.1111/j.1600-0609.1996.tb01384.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNiitsu, N | |
| 245 | 0 | 0 |
_aSalvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin, etoposide and steroids) therapy. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology _cOct 1996 |
||
| 300 |
_a320-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aUmeda, M | |
| 773 | 0 |
_tEuropean journal of haematology _gvol. 57 _gno. 4 _gp. 320-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1996.tb01384.x _zAvailable from publisher's website |
| 999 |
_c8973773 _d8973773 |
||